1. Davis S.S. (1986): Advanced delivery systems for peptides and proteins — pharmaceutical considerations. In: Davis S.S. Ilium, L. Tomlinson E. (eds). Delivery Systems for Peptide Drugs. New York, Plenum Press, 1–21.
2. Ogawa Y., Tomida Y. (1989): Development of lupron depot. Pharma. Tech. Japan, 5, 37–43 (Japanese).
3. Sanders L.M., Vitale K.M., McRae G.M., Mishky P.B. (1986): Controlled delivery of nafarelin, an agonistic analogue of LHRH, from microspheres of poly (D,L lactic-co-glycolic acid). In: Proceedings of NATO Workshop on Advanced Drug Delivery Systems for Peptides and Proteins. New York, Plenum Press, 125–137.
4. Thies C. (1982): Microcapsules as drug delivery devices. CRC Crit. Rev. Biomed. Eng., 8, 335–383.
5. Kent J.S., Sanders L.M., Tice T.R., Lewis D.H. (1984): Microencapsulation of the peptide nafarelin for controlled release. In: Zatuchni G.I., Goldsmith A., Shelton J.D., Sciarra J.J., (eds). Long Acting Contraceptive Delivery Systems. Harper & Row, 169–179.